Skip to main content
Key Specialties
Cardiology Diabetology Endocrinology Gastroenterology Geriatrics and Gerontology Gynecology and Obstetrics Hematology Infectious Disease Internal Medicine Nephrology Neurology Oncology Pediatrics Respiratory Medicine Rheumatology Surgery
Congress Coverage
2024 ACC Congress 2023 ESMO Congress 2023 EASD Congress 2023 ERS Congress 2023 ESC Congress 2023 EHA Congress 2023 ASCO Annual Meeting
Clinical Collections
Advances in Alzheimer’s

Keynote webinar | Spotlight on sleep in brain health

LIVE: Thursday 2nd May 2024, 18:00-19:30 (CEST)

Quality sleep is essential for health. But what happens to our brains when sleep patterns are disturbed? Join our experts to explore the interplay between sleep disruption and neurological diseases, and the questions that you need to be asking your patients to help you prevent the harmful effects of sleep deprivation.
ADVANCED SEARCH
Log in
Top
European Journal of Nuclear Medicine and Molecular Imaging
Literature
1.
2.
Parker C, et al. Alpha emitter radium-223 and survival in metastatic prostate cancer. N Engl J Med. 2013;369(3):213–23.CrossRefPubMed
3.
Verheijen RH, et al. Phase III trial of intraperitoneal therapy with yttrium-90-labeled HMFG1 murine monoclonal antibody in patients with epithelial ovarian cancer after a surgically defined complete remission. J Clin Oncol. 2006;24(4):571–8.CrossRefPubMed
4.
Bodei L, et al. Long-term tolerability of PRRT in 807 patients with neuroendocrine tumours: the value and limitations of clinical factors. Eur J Nucl Med Mol Imaging. 2015;42(1):5–19.CrossRefPubMed
5.
Del Prete M, et al. Personalized 177Lu-octreotate peptide receptor radionuclide therapy of neuroendocrine tumours: initial results from the P-PRRT trial. Eur J Nucl Med Mol Imaging. 2019;46(3):728–42.CrossRefPubMed
6.
Pouget JP, et al. Introduction to radiobiology of targeted radionuclide therapy. Front Med. 2015;2:12.CrossRef
7.
European Association of Nuclear Medicine Internal Dosimetry Task Force Report, Treatment planning for molecular radiotherapy: potential and prospects. Flux G, Stokke C., editors. 2017.
8.
European Council Directive. 2013/59/Euratom of 5 December 2013 laying down basic safety standards for protections against the dangers arising from exposure to ionising radiation, and repealing Directives 89/618/Euratom, 90/641/Euratom, 96/29/Euratom, 97/43/Euratom and 2003/122/Euratom. Off J Eur Union. 2014.
9.
10.
Metadata
Title
Call to arms: need for radiobiology in molecular radionuclide therapy
Authors
Samantha Y. A. Terry
Julie Nonnekens
An Aerts
Sarah Baatout
Marion de Jong
Bart Cornelissen
Jean-Pierre Pouget
Publication date
01-07-2019
Publisher
Springer Berlin Heidelberg
Published in
European Journal of Nuclear Medicine and Molecular Imaging / Issue 8/2019
Print ISSN: 1619-7070
Electronic ISSN: 1619-7089
DOI
https://doi.org/10.1007/s00259-019-04334-3

Other articles of this Issue 8/2019

European Journal of Nuclear Medicine and Molecular Imaging 8/2019 Go to the issue

Book Review

Eugene C. Lin and Abass Alavi (Eds): PET and PET/CT. A Clinical Guide. Third Edition

Letter to the Editor

Transfer of yttrium-90 to breast milk during radiosynoviorthesis of the knee joint

Letter to the Editor

Small-voxel reconstructions significantly influence SUVs in PET imaging

Original Article

[18F]FDG PET/CT in non-union: improving the diagnostic performances by using both PET and CT criteria

Original Article

[68Ga]Pentixafor PET/MR imaging of chemokine receptor 4 expression in the human carotid artery

Original Article

Distinct FP-CIT PET patterns of Alzheimer’s disease with parkinsonism and dementia with Lewy bodies